Samalin Investment Counsel, LLC Abbott Laboratories Transaction History

Samalin Investment Counsel, LLC

$222 Million
Q3 2024

A detailed history of Samalin Investment Counsel, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Samalin Investment Counsel, LLC holds 3,769 shares of ABT stock, worth $432,530. This represents 0.19% of its overall portfolio holdings.

Number of Shares

3,769

Previous 3,968 5.02%

Holding current value

$432,530

Previous $412,000 4.13%

% of portfolio

0.19%

Previous 0.2%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$100.07 - $118.13 $19,913 - $23,507	-199 Reduced 5.02%	3,769 $429,000
Q2 2024 Aug 13, 2024	BUY	$100.73 - $112.44 $71,820 - $80,169	713 Added 21.9%	3,968 $412,000
Q1 2024 May 13, 2024	SELL	$109.52 - $120.96 $151,575 - $167,408	-1,384 Reduced 29.83%	3,255 $369,000
Q4 2023 Feb 14, 2024	BUY	$90.19 - $110.4 $4,689 - $5,740	52 Added 1.13%	4,639 $510,000
Q3 2023 Nov 13, 2023	SELL	$95.53 - $114.62 $19,965 - $23,955	-209 Reduced 4.36%	4,587 $444,000
Q2 2023 Aug 03, 2023	BUY	$100.78 - $112.29 $12,799 - $14,260	127 Added 2.72%	4,796 $522,000
Q1 2023 May 09, 2023	SELL	$96.86 - $114.01 $7,942 - $9,348	-82 Reduced 1.73%	4,669 $472,000
Q4 2022 Feb 10, 2023	BUY	$95.06 - $111.52 $380 - $446	4 Added 0.08%	4,751 $521,000
Q3 2022 Nov 10, 2022	BUY	$96.76 - $112.03 $290 - $336	3 Added 0.06%	4,747 $459,000
Q2 2022 Aug 15, 2022	BUY	$102.07 - $123.37 $10,411 - $12,583	102 Added 2.2%	4,744 $515,000
Q1 2022 Oct 13, 2022	BUY	$114.02 - $139.04 $151,760 - $185,062	1,331 Added 40.2%	4,642 $549,000
Q1 2022 May 16, 2022	BUY	$114.02 - $139.04 $151,760 - $185,062	1,331 Added 40.2%	4,642 $549 Million
Q4 2021 Oct 13, 2022	BUY	$115.53 - $141.46 $19,871 - $24,331	172 Added 5.48%	3,311 $466,000
Q4 2021 Feb 15, 2022	BUY	$115.53 - $141.46 $19,871 - $24,331	172 Added 5.48%	3,311 $466 Million
Q3 2021 Oct 13, 2022	BUY	$116.66 - $129.06 $349 - $387	3 Added 0.1%	3,139 $371,000
Q3 2021 Nov 15, 2021	BUY	$116.66 - $129.06 $349 - $387	3 Added 0.1%	3,139 $371 Million
Q2 2021 Oct 13, 2022	BUY	$105.79 - $124.53 $33,323 - $39,226	315 Added 11.17%	3,136 $364,000
Q2 2021 Aug 12, 2021	BUY	$105.79 - $124.53 $10,579 - $12,453	100 Added 3.29%	3,136 $363,000
Q1 2021 May 11, 2021	BUY	$108.84 - $128.23 $23,400 - $27,569	215 Added 7.62%	3,036 $363,000
Q4 2020 Oct 13, 2022	SELL	$105.0 - $114.42 $60,480 - $65,905	-576 Reduced 16.96%	2,821 $309,000
Q4 2020 Feb 09, 2021	SELL	$105.0 - $114.42 $60,480 - $65,905	-576 Reduced 16.96%	2,821 $309 Million
Q3 2020 Oct 13, 2022	SELL	$91.64 - $111.29 $123,439 - $149,907	-1,347 Reduced 28.39%	3,397 $370,000
Q3 2020 Nov 10, 2020	SELL	$91.64 - $111.29 $21,627 - $26,264	-236 Reduced 6.5%	3,397 $369,000
Q2 2020 Aug 05, 2020	BUY	$76.57 - $98.0 $8,422 - $10,780	110 Added 3.12%	3,633 $332,000
Q1 2020 May 04, 2020	SELL	$62.82 - $91.86 $55,470 - $81,112	-883 Reduced 20.04%	3,523 $278,000
Q4 2019 Feb 05, 2020	BUY	$78.51 - $87.4 $345,915 - $385,084	4,406 New	4,406 $382,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $201B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Samalin Investment Counsel, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Samalin Investment Counsel, LLC with notifications on news.

Account

Samalin Investment Counsel, LLC Abbott Laboratories Transaction History